Skip to content

Author

S. Hageman

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Incremental value of cardiac biomarkers and cancer-related factors beyond SCORE2 for prediction of cardiovascular events

Cancer therapy-related cardiovascular (CV) disease is an increasing cause of morbidity and mortality among cancer survivors. Current guidelines recommend CV risk prediction tools such as SCORE2; however, these do not account for cancer-specific factors or cardiac biomarkers. Whether incorporating cardio-oncology...

M. Gynnild, H. Dalen, E. Holte et al. · 0 citations
Open access Oct 2026

Three decades of secondary prevention in ASCVD: temporal trends in risk factors and recurrent cardiovascular events

Patients with established atherosclerotic cardiovascular disease (ASCVD) are at high risk of recurrent events. Over recent decades, guidelines have intensified secondary prevention strategies targeting risk factors, including low-density lipoprotein-cholesterol (LDL-c), systolic blood pressure (SBP), smoking cess...

E. Wempe, Y. van der Schouw, F. Martens et al. · 0 citations
Open access Oct 2026

Relationship between Lipoprotein(a) and subsequent cardiovascular events in patients with different locations of established cardiovascular disease

Higher levels of Lp(a) consistently increased the risk of subsequent cardiovascular outcomes, specifically myocardial infarction and coronary or other vascular interventions, across all locations of established ASCVD.

J. Ebbers, E. Haug, M. Gynnild et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.